OpenVSafe by OpenVAERS
Search V-safe

7RS-29780-78133

4 vaccinations 4 coded responses 30 check-ins 3 free-text entries 2 call cases
Sex
Male
Age at first dose
61-65
ZIP prefix
708 / LA
Registered
2021-03-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2257507 (opens in a new window) high 11 / 11 3 3 of 5 VAERS symptoms same dose (3) LA matches 2021-10-26 / 2022-01-20 / 2022-04-28
received the same day as the last call
case 593356

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-03-01
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-05
    Registered in v-safe
  3. 2021-03-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-03-08
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-15
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  6. 2021-03-22
    Dose 2 — Pfizer-BioNTech
  7. 2021-03-22
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  8. 2021-03-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site discolouration, Pyrexia — Feeling: Good
    Free text: Slightly sore at injection site but not painful. May have had a slight increase in temperature, but not enough to feel feverish.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-03-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-03-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-03-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-03-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-29
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-04-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-04-12
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-04-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-04-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-05-03
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-06-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-09-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-10-26
    Dose 3 — Pfizer-BioNTech
  23. 2022-01-30
    Survey response — 3 months, dose 3
    MedDRA: Cough, Fatigue, Nasopharyngitis, Night sweats, Respiratory tract congestion, SARS-CoV-2 test positive, Unevaluable event — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Tested positive for Covid-19 on January 21, 2021. Symptoms started the evening of January 19th, seemed like a head cold. On 20th had a cough and workplace sent me for test on 21st. Had chest congestion , and night sweats 21st, 22nd and fatigued. · Healthcare visit (other): Prescribed Tessalon 200 mg and Flovent HFA.
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-01-30
    Report sent to call center — 3 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  25. 2022-02-01
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
  26. 2022-04-26
    Survey response — 6 months, dose 3
    MedDRA: Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Felt like a bad cold.
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-04-26
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  28. 2022-04-27
  29. 2022-04-28
  30. 2022-04-28
    Call successful
    Completed over the phone
  31. 2022-10-20
    Dose 4 — Pfizer-BioNTech
  32. 2022-10-26
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-10-26
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  34. 2022-10-27
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  35. 2022-11-04
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-11-10
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  37. 2022-11-17
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-11-24
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-12-02
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  40. 2023-01-20
    Survey response — 3 months, dose 4
    MedDRA: Lower respiratory tract infection, Nasopharyngitis, SARS-CoV-2 test negative — Feeling: Fair
    MedDRA releases: 2024-11
  41. 2023-04-20
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-01Pfizer-BioNTech
22021-03-22Pfizer-BioNTech
32021-10-26Pfizer-BioNTech No
42022-10-20Pfizer-BioNTech No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 1

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-23

Systemic reaction (other): Slightly sore at injection site but not painful. May have had a slight increase in temperature, but not enough to feel feverish.

Release 11 — 3 months, dose 3

2022-01-30

Symptoms: Tested positive for Covid-19 on January 21, 2021. Symptoms started the evening of January 19th, seemed like a head cold. On 20th had a cough and workplace sent me for test on 21st. Had chest congestion , and night sweats 21st, 22nd and fatigued. cut off by CDC
Healthcare visit (other): Prescribed Tessalon 200 mg and Flovent HFA.

Release 11 — 6 months, dose 3

2022-04-26

Symptoms: Felt like a bad cold.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUnevaluable event · · ✓
SDCough · · ✓
SDFatigue · · ✓
SDLower respiratory tract infection · · ✓
SDNasopharyngitis · · ✓
SDNight sweats · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSARS-CoV-2 test positive · · ✓
SROInjection site discolouration ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release